Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
IUBMB Life ; 75(9): 732-742, 2023 09.
Artículo en Inglés | MEDLINE | ID: mdl-37086464

RESUMEN

Beyond its actions on the nervous system, amitriptyline (AM) has been shown to lower inflammatory, angiogenic, and fibrogenic markers in a few pathological conditions in human and in experimental animal models. However, its effects on foreign body reaction (FBR), a complex adverse healing process, after biomedical material implantation are not known. We have evaluated the effects of AM on the angiogenic and fibrogenic components on a model of implant-induced FBR. Sponge disks were implanted subcutaneously in C57BL/6 mice, that were treated daily with oral administration of AM (5 mg/kg) for seven consecutive days in two protocols: treatment was started on the day of surgery and the implants were removed on the seventh day after implantation and treatment started 7 days after implantation and the implants removed 14 after implantation. None of the angiogenic (vessels, Vascular endothelial growth factor (VEGF), and interleukin-1ß (IL-1ß) or fibrogenic parameters (collagen, TGF-ß, and fibrous capsule) and giant cell numbers analyzed were attenuated by AM in 7-day-old implants. However, AM was able to downregulate angiogenesis and FBR in 14-day-old implants. The effects of AM described here expands its range of actions as a potential agent capable of attenuating fibroproliferative processes that may impair functionality of implantable devices.


Asunto(s)
Amitriptilina , Factor A de Crecimiento Endotelial Vascular , Ratones , Animales , Humanos , Amitriptilina/farmacología , Factor A de Crecimiento Endotelial Vascular/genética , Factor A de Crecimiento Endotelial Vascular/metabolismo , Ratones Endogámicos C57BL , Reacción a Cuerpo Extraño/inducido químicamente , Reacción a Cuerpo Extraño/metabolismo , Reacción a Cuerpo Extraño/patología , Colágeno/metabolismo
2.
Nutrients ; 16(18)2024 Sep 19.
Artículo en Inglés | MEDLINE | ID: mdl-39339767

RESUMEN

BACKGROUND: Capsaicin, a bioactive compound found in peppers, is recognized for its anti-inflammatory, antioxidant, and anti-lipidemic properties. This study aimed to evaluate the effects of capsaicin on atherosclerosis progression. METHODS: Apolipoprotein E knockout mice and their C57BL/6 controls were utilized to assess blood lipid profile, inflammatory status, and atherosclerotic lesions. We also examined the influence of capsaicin on cholesterol influx and efflux, and the role of TRPV1 and PPARγ signaling pathways in bone marrow-derived macrophages. RESULTS: Capsaicin treatment reduced weight gain, visceral adiposity, blood triglycerides, and total and non-HDL cholesterol. These improvements were associated with a reduction in atherosclerotic lesions in the aorta and carotid. Capsaicin also improved hepatic oxidative and inflammatory status. Systemic inflammation was also reduced, as indicated by reduced leukocyte rolling and adhesion on the mesenteric plexus. Capsaicin decreased foam cell formation by reducing cholesterol influx through scavenger receptor A and increasing cholesterol efflux via ATP-binding cassette transporter A1, an effect primarily linked to TRPV1 activation. CONCLUSIONS: These findings underscore the potential of capsaicin as a promising agent for atherosclerosis prevention, highlighting its comprehensive role in modulating lipid metabolism, foam cell formation, and inflammatory responses.


Asunto(s)
Aterosclerosis , Capsaicina , Células Espumosas , Inflamación , Ratones Endogámicos C57BL , PPAR gamma , Canales Catiónicos TRPV , Animales , Canales Catiónicos TRPV/metabolismo , Aterosclerosis/prevención & control , Aterosclerosis/tratamiento farmacológico , Capsaicina/farmacología , Células Espumosas/efectos de los fármacos , Células Espumosas/metabolismo , PPAR gamma/metabolismo , Inflamación/tratamiento farmacológico , Ratones , Masculino , Colesterol/sangre , Colesterol/metabolismo , Ratones Noqueados para ApoE , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Transportador 1 de Casete de Unión a ATP/metabolismo , Ratones Noqueados , Antiinflamatorios/farmacología , Metabolismo de los Lípidos/efectos de los fármacos , Transducción de Señal/efectos de los fármacos
3.
Eur J Pharmacol ; 934: 175255, 2022 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-36088982

RESUMEN

BACKGROUND AND PURPOSE: Amitriptyline (AM) is a classical and typical tricyclic antidepressant drug. Despite its well-known effects on the nervous system, it has been described to work as a TLR4 antagonist and several clinical works suggested some unexpected cardiovascular effects. The role of amitriptyline on vascular tone is not clear, thus we hypothesized that amitriptyline has a double effect on vascular tone by both endothelial TLR4-dependent nitric oxide down-regulation and calcium channel blockade in smooth muscle cells. EXPERIMENTAL APPROACH: Changes in isometric tension were recorded on a wire myograph. NO production was evaluated by fluorescence microscopy and flow cytometry in the mouse aorta and EAhy926 cells using DAF fluorescence intensity. Calcium influx was evaluated in A7r5 cells by flow cytometry. Western blot was used to analyze eNOS and nNOS phosphorylation. KEY RESULTS: AM reduced PE-induced contraction by calcium influx diminution in smooth muscle cells (F/F0 = 225.6 ± 15.9 and 118.6 ± 17.6 to CT and AM, respectively). AM impaired Ach-dependent vasodilation (Emax = 95.8 ± 1.4; 78.1 ± 1.8; 60.4 ± 2.9 and -7.4 ± 1.0 for CT, 0.01, 0,1 and 1 µmol/L AM, respectively) through reduction of calcium influx and NO availability and TLR4 antagonism in a concentration-dependent manner. AM or TLR4 gene deletion significantly reduced NO production (Fluorescence = 9503 ± 871.7, 2561 ± 282, 4771 ± 728 and 1029 ± 103 to CT, AM, TLR4-/- and AM + TLR4-/-, respectively) by an increase in nNOSser852 and reduction in eNOSser1177 phosphorylation in endothelial cells. CONCLUSIONS AND IMPLICATIONS: Our data show that amitriptyline impaired vascular function through two different mechanisms: blockade of TLR4 in endothelial cells and consequent decrease in NO production and calcium influx reduction in smooth muscle and endothelial cells. We also suggest, for the first time, nNOS activity reduction by AM in non-neuronal cells.


Asunto(s)
Canales de Calcio , Células Endoteliales , Ratones , Animales , Amitriptilina/farmacología , Receptor Toll-Like 4 , Óxido Nítrico/metabolismo , Endotelio Vascular , Calcio/metabolismo , Antidepresivos Tricíclicos/farmacología , Ratones Endogámicos C57BL , Vasodilatación , Miocitos del Músculo Liso/metabolismo
4.
Biol Pharm Bull ; 34(9): 1499-500, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21881240

RESUMEN

The present work aimed to investigate the vasorelaxant effect of isotirumalin, a dihydroflavonol isolated from Derris urucu (Leguminosae). The vasorelaxant effect of isotirumalin was investigated in the rat aorta, in the presence and in the absence of a functional endothelium. The production of nitric oxide (NO) induced by isotirumalin was measured simultaneously with its vasorelaxation using carbon microsensors. In endothelium-intact aortic rings, isotirumalin induced a concentration-dependent vasodilator effect the concentration required to produce 30% of relaxation (pIC30=4.84±0.24) that was abolished in endothelium-denuded aortic rings or in the presence of Nω-nitro-L-arginine-methyl-ester (L-NAME; 300 µM). In addition, isotirumalin (100 µM) induced a simultaneous and significant increase on NO production, which was blunted in the presence of L-NAME. The present results demonstrate that isotirumalin is a vasodilator in the rat aorta and act by a mechanism dependent on the presence of a functional endothelium and on NO production.


Asunto(s)
Aorta/efectos de los fármacos , Derris/química , Endotelio Vascular/efectos de los fármacos , Flavonoles/farmacología , Óxido Nítrico/fisiología , Vasodilatadores/farmacología , Animales , Aorta/fisiología , Endotelio Vascular/fisiología , Técnicas In Vitro , Masculino , Ratas , Ratas Wistar
5.
Inflammation ; 44(2): 580-591, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33034827

RESUMEN

Recent data has signaled that in addition to its therapeutic indications as antidepressant and analgesic, amitriptyline (AM) exerts anti-inflammatory effects in humans and experimental animal models of acute inflammation. We tested the hypothesis that this compound could also modulate the chronic inflammatory process induced by synthetic matrix in mice. Polyether-polyurethane sponge disks were implanted subcutaneously in 9-week-old male C57BL/6 mice. The animals received by oral gavage 5.0 mg/kg of amitriptyline for seven consecutive days in two treatment regimens. In the first series, the treatment was initiated on the day of surgery and the implants removed at day 7 post-implantation. For the assessment of the effect of amitriptyline on chronic inflammation, the treatment was initiated 7 days post-implantation and the sponge discs removed 14 after implantation. The inflammatory markers evaluated, myeloperoxidase - MPO, nitrite content, IL-6, IFN-γ, TNF-α, CXCL1 and CCL2 levels, and NF-κB transcription factor activation were reduced in implants when the treatment began 7 days post-implantation (chronic inflammation). In contrast, only mast cell number, MPO activity and activation of NF-κB pathway decreased when the treatment began soon after implantation (sub-acute inflammation) in 7-day old implants. The anti-inflammatory effects of amitriptyline described here, extend its range of actions as a potential agent able to attenuate long-term inflammatory processes.


Asunto(s)
Amitriptilina/uso terapéutico , Antiinflamatorios/uso terapéutico , Materiales Biocompatibles/efectos adversos , Inflamación/tratamiento farmacológico , Poliuretanos/efectos adversos , Animales , Biomarcadores/metabolismo , Western Blotting , Enfermedad Crónica , Citocinas/metabolismo , Regulación hacia Abajo , Inflamación/diagnóstico , Inflamación/etiología , Inflamación/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Resultado del Tratamiento
6.
Rev Bras Parasitol Vet ; 29(2): e000420, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32609238

RESUMEN

Angiostrongylus vasorum is a pulmonary artery parasite of domestic and wild canid. On molluscs, intermediate host, first stage larvae (L1) are found after the first day of infection, in the 8th L2 and in the 30 th L3. It was evaluated L1, L2 and L3 recovered by Baermann technique from Achatina fulica infected with 1000 L1. Fifty larvae/stage were incubated with antibodies anti-ß-tubulin, anti-α-tubulin, anti- α-actin, anti-ß-actin and anti-collagen, and then with Alexa 633. Fifty larvae/stage were observed with picrosirius red and Oil Red O. It was also observed in the anterior region of L1 the beginning of the chitinous stems development, in the initial portion of the intestine and genital primordium. In L2 anterior region, the papillae, chitinous canes juxtaposed to the mouth and intestines bigger than L1. The L3 musculature is well defined, next to the chitinous stems, there are two round distally arranged from each other. It was observed the whole extension of the intestine genital primordium and intense cellularity in the L3 distal portion. With the picrosirius red the L1, L2 and L3 musculature could be observed, as the nerve ganglia on L3. Oil Red O revealed that L1, L2 and L3 store energy on lipid droplets.


Asunto(s)
Angiostrongylus , Gastrópodos , Parasitología , Angiostrongylus/anatomía & histología , Animales , Gastrópodos/parasitología , Larva/anatomía & histología , Parasitología/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA